Diagnosis and treatment of pure red cell aplasia caused by human parvovirus B19 after liver transplantation: Report of one case and literature review
10.3760/cma.j.issn.0254-1785.2016.03.004
- VernacularTitle:肝移植后人细小病毒B19感染导致单纯红细胞再生障碍性贫血一例
- Author:
Qingqi REN
;
Weiqiang JU
;
Dongping WANG
;
Zhiyong GUO
;
Maogen CHEN
;
Xiaoshun HE
- Publication Type:Journal Article
- Keywords:
Parvovirus B19,human;
Red-cell aplasia,pure;
Liver transplantation;
Immunosuppressive agents
- From:
Chinese Journal of Organ Transplantation
2016;37(3):144-149
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the diagnosis and treatment of pure red cell aplasia (PRCA) caused by human parvovirus B19 (HPVB19) after liver transplantation.Method The clinical data of one case of PRCA caused by HPVB19 after liver transplantation,including clinical manifestations,diagnosis and treatment,were retrospectively analyzed,and the related literatures were reviewed.Result The first case of PRCA caused by HPVB19 after liver transplantation in our center with typical clinical manifestations of anemia was diagnosed,including dizziness,fatigue,anhelation and so on.A progressive decrease in erythrocyte count,reticulocyte count and hemoglobin level were observed by blood routine test.Bone marrow aspiration biopsy showed an absence of erythroid cells and the HPVB19 DNA test of blood was positive.Erythrocyte count,reticulocyte count and hemoglobin level were back to normal after the anti-rejection strategy changing from tacrolimus and rapamycin to cyclosporin and rapamycin and a normal human myelogram was observed by bone marrow aspiration biopsy.The DNA concentration of HPVB19 in blood was below the lower test limit.The blood test of HPVB19 DNA showed a positive result again after the anti-rejection strategy changed back to tacrolimus and rapamycin duo to increased blood creatinine level while the reticulocyte count was still in normal scale.This is the first reported case of successfully cured PRCA caused by HPVB19 in liver transplantation patients through changing the anti-rejection strategy and also the first case of HPVB19 re-infection or relapse without PRCA recurrence in liver transplantation patients.Conclusion This case may indicate the importance of immunosuppressive drug changing in the treatment of liver recipients suffering from PRCA caused by HPVB19 infection,and the genotype test may promote the understanding and treatment for this disease.
